mRNA
AMCAP™ Cas9 mRNA
Price range: 300,00 € through 1.700,00 €
AMCAP ™ mRNA is capped with Cap 1 structure and contains 100A tail in its sequence.
Description
AMCAP ™ Cas9 mRNA expresses the Cas9 protein, a crucial component of the CRISPR-Cas9 gene editing system. Cas9 is an RNA-guided DNA endonuclease that can be programmed to target specific DNA sequences.
This mRNA is capped with a Cap1 structure with high capping efficiency and designed with a 100A tail to mimic mature mRNA. Cas9 mRNA is a versatile tool that can be used to study a variety of biological processes, including gene editing, gene regulation, and genome engineering. It is a valuable tool for researchers in a variety of fields, including genetics, molecular biology, and biotechnology. This protein can then be used to introduce targeted modifications to the genome. Cas9 mRNA is a versatile tool for researchers studying a variety of biological processes. Its ability to express Cas9 makes it a valuable tool for developing gene therapies and other applications of CRISPR-Cas9 technology.
Data & IP Statements
Products are not for resale without express written permission from Anemocyte s.r.l.
Any and all Intellectual Property Rights (means any and all rights in and to any and all intellectual property – whether registerable or patentable or not – including, but not limited to, names, trademarks, domain, trade names, designs, works of authorship, patents for inventions and utility models, processes, trade secrets, software, platforms, technology, know-how, sequencies and any other intellectual property) belong to Anemocyte s.r.l., which is their full, exclusive and unconditional owner, or are lawfully held or otherwise within legitimate possession or control of Anemocyte s.r.l.
No license under any patent or other Intellectual Property Rights of Anemocyte s.r.l. or its licensors is granted or implied by the purchase unless otherwise provided in writing.
Without prejudice to the foregoing, these products are manufactured using a Anemocyte s.r.l technology which is currently patent pending. Anemocyte s.r.l does not warrant that the use or sale of the products will not infringe the claims of any patents or patents pending, covering the use of the product alone or in combination with other products or in the operation of any process.
For further information contact sales@anemocyte.com
SEQUENCE
AMCAP™ Cas9 mRNAFORMULATION
1 mM sodium citrate buffer (pH 6.4).
INTENDED USE
For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. The purchaser has sole responsibility for all and any use of the products.
![](https://shop.anemocyte.com/wp-content/themes/ANEMOCYTE/img/download-cloud.svg")
Download Specification Sheet - R&D
